Medicare News, In Brief
Executive Summary
Part D Discounts On Low-Volume Claims
You may also be interested in...
Medicare Drug Price Substitution For Part B Proposed Again By CMS
The proposal to reimburse less for drugs that exceed a price substitution threshold, first made last year but never finalized, is part of the Physician Fee Schedule proposed rule for 2012.
Industry Pressures CMS To Hold ASP Plus 6 Percent Rate For Hospital Outpatient Drugs
CMS' proposal to bring the reimbursement rate for Medicare Part B drugs administered in hospital outpatient departments back to average sales price plus 6% for the first time since 2007 has resulted in a fresh wave of pressure from industry groups to keep it at that level.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.